SCHEMBL13620346

SCHEMBL13620346

Cc1cnn(O)c(=O)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
GRIA4 P48058 1/20 0.39
KAT2B Q92831 3/20 0.36
BRD9 Q9H8M2 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
ALDH1A1 P00352 7/20 0.35
HTT P42858 5/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
RAB9A P51151 7/20 0.34
NPC1 O15118 5/20 0.34
LMNA P02545 4/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 3/20 0.34
MITF O75030 2/20 0.34
RECQL P46063 1/20 0.34
S1PR4 O95977 2/20 0.34
S1PR1 P21453 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14385184 0.80 HTT (0.50) ALDH1A1HTTSMN1; SMN2RAB9ANPC1
SCHEMBL13620347 0.78 KAT2B (0.36) KAT2BBRD9GABRA1GABRB2ALDH1A1
SCHEMBL14074017 0.78 KAT2B (0.58) KAT2BBRD9ALDH1A1RAB9AMAPT
SCHEMBL17738012 0.74 SMN1; SMN2 (0.50) KAT2BBRD9ALDH1A1HTTSMN1; SMN2
SCHEMBL13562543 0.71 NPBWR1 (0.56) ALDH1A1HTTSMN1; SMN2RAB9ANPC1
SCHEMBL16884990 0.69
SCHEMBL18454995 0.67 HTT (0.59) ALDH1A1HTTSMN1; SMN2RAB9ANPC1
SCHEMBL18532426 0.67 GAA (0.56) ALDH1A1HTTSMN1; SMN2RAB9ANPC1
SCHEMBL18446084 0.65 RAB9A (0.78) KAT2BBRD9ALDH1A1HTTSMN1; SMN2
SCHEMBL18979930 0.64 NPSR1 (0.76) ALDH1A1HTTSMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2123264-A1 Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure Allergan, Inc. (US) 2009-11-25 EP disclosed